These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7477660)

  • 1. Lipoprotein(a) levels in hemodialysis patients: relation to glucose intolerance and hemodialysis duration.
    Fiorini F; Masturzo P; Mij M; Bertolini S
    Nephron; 1995; 70(4):500-1. PubMed ID: 7477660
    [No Abstract]   [Full Text] [Related]  

  • 2. Are the increased Lp(a) levels in hemodialysis patients related to glucose intolerance and hemodialysis duration?
    Elisaf M; Siamopoulos KC
    Nephron; 1996; 74(3):623-4. PubMed ID: 8938695
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased lipoprotein (a) levels in subjects with chronic renal failure on hemodialysis.
    Barbagallo CM; Averna MR; Scafidi V; Galione A; Notarbartolo A
    Nephron; 1992; 62(4):471-2. PubMed ID: 1300447
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
    Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
    Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) in chronic renal failure patients undergoing hemodialysis: does it have an independent role in the development of further cardiovascular complications?
    del Cura J; Gil-Paraiso A; Borque L; Carazo ME; Maside C; Sánchez-Casajús A
    Nephron; 1993; 65(4):644-5. PubMed ID: 8302428
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein (a) in patients on hemodialysis.
    Díaz-Peromingo JA; Carbajal DG; Albán-Salgado A
    Acta Med Austriaca; 2004 Aug; 31(3):73-5. PubMed ID: 15515480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus.
    Makino K; Josephson MA; Fellner SK; Scanu AM
    Atherosclerosis; 1993 Jan; 98(2):255-6. PubMed ID: 8457265
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
    Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
    Nephron; 1993; 65(1):46-50. PubMed ID: 8413789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.
    Parra HJ; Mezdour H; Cachera C; Dracon M; Tacquet A; Fruchart JC
    Clin Chem; 1987 May; 33(5):721. PubMed ID: 2952378
    [No Abstract]   [Full Text] [Related]  

  • 11. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
    Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
    Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation activation in extracorporeal hemodialysis.
    Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
    Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
    Barbagallo CM; Averna MR; Sparacino V; Galione A; Caputo F; Scafidi V; Amato S; Mancino C; Cefalù AB; Notarbartolo A
    Nephron; 1993; 64(4):560-4. PubMed ID: 8366981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Flaxseed Oil on Serum Lipids and Lipoproteins in Hemodialysis Patients: a Randomized Controlled Trial.
    Mirfatahi M; Tabibi H; Nasrollahi A; Hedayati M
    Iran J Kidney Dis; 2016 Nov; 10(6):405-412. PubMed ID: 27904000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional versus ultrapure dialysate for lowering serum lipoprotein(a) levels in patients on long-term hemodialysis: a randomized trial.
    Tao J; Sun Y; Li X; Li H; Liu S; Wen Y; Duan L; Li Y; Li X
    Int J Artif Organs; 2010 May; 33(5):290-6. PubMed ID: 20593350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.
    Hernández E; Praga M; Alamo C; Araque A; Morales JM; Alcazar JM; Ruilope LM; Rodicio JL
    Nephron; 1996; 72(2):145-9. PubMed ID: 8684517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.
    Heimann P; Josephson MA; Fellner SK; Thistlethwaite JR; Stuart FP; Dasgupta A
    Am J Nephrol; 1991; 11(6):470-4. PubMed ID: 1840233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticardiolipin antibodies and lipoprotein (a) levels in patients with chronic renal failure treated with dialysis: associations with atherothrombotic disease.
    Petersen LJ; Ringsdal VS; Ladefoged SD; Baslund B; Hansen PR
    Int J Artif Organs; 1996 Jun; 19(6):339-42. PubMed ID: 8814496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.